Stock SZLS STAGEZERO LIFE SCIENCES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company StageZero Life Sciences Ltd.

Equities

SZLS

CA8525403017

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 11:00:00 2024-04-16 am EDT 		5-day change 1st Jan Change
0.04 CAD -.--% Intraday chart for StageZero Life Sciences Ltd. -.--% -11.11%
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ
Apr. 04 North American Morning Briefing : Focus Turns to -2- DJ

Business Summary

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

Number of employees: 40

Sales per Business

CAD in Million2021Weight2022Weight Delta
Clinical Consultation
79.7 %
- - 4 79.7 % -
Laboratory Testing
20.3 %
- - 1 20.3 % -

Sales per region

CAD in Million2021Weight2022Weight Delta
North America
70.0 %
-- 3 70.0 % -
Western Europe
30.0 %
-- 1 30.0 % -

Managers

Managers TitleAgeSince
James Howard-Tripp CEO
 Chief Executive Officer - 01-12-31
Rebecca Greco IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Rory Riggs FOU
 Founder 71 97-12-31
Garth MacRae BRD
 Director/Board Member 90 99-12-31
James Howard-Tripp CEO
 Chief Executive Officer - 01-12-31
Harry Glorikian BRD
 Director/Board Member 58 08-06-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 123,532,981 98,370,853 ( 79.63 %) 0 79.63 %

Shareholders

NameEquities%Valuation
Rory Riggs
10.19 %
12,522,906 10.19 % 438 302 $
James Howard-Tripp
0.1893 %
232,759 0.1893 % 8 147 $
B.E.S.T. Investment Counsel Ltd.
0.1546 %
190,076 0.1546 % 6 653 $
Garth MacRae
0.1196 %
147,086 0.1196 % 5 148 $
Harry Glorikian
0.0872 %
107,154 0.0872 % 3 750 $
Fiera Holdings, Inc.
0.001527 %
1,878 0.001527 % 66 $
BluMont Capital Corp.
0.000188 %
231 0.000188 % 8 $

Company contact information

StageZero Life Sciences Ltd.

70 East Beaver Creek Road Unit 30

L4B 3B2, Richmond Hill

+

http://www.stagezerolifesciences.com
address StageZero Life Sciences Ltd.(SZLS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
STAGEZERO LIFE SCIENCES LTD. Stock StageZero Life Sciences Ltd.
-11.11% 3.6M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.17% 42.19B
MODERNA, INC. Stock Moderna, Inc.
+10.92% 42.24B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 40.15B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.23% 24.63B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.79% 18.2B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.69% 12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.13% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.57% 10.4B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SZLS Stock
  4. Company StageZero Life Sciences Ltd.